pocketful logo light
pocketful logo light
Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM BSE: 500420

₹5122.80

(5.15%)

Mon, 10 Aug 2026, 11:15 am

mtf coin illustrationMTF 5x

Torrent Pharmaceuticals Share Price Live Chart

1 Day

(5.15%)

No Result Found

Summary

  • Market Cap (in Cr)

    148718

  • Net Profit (in Cr)

    1911.25

  • P/B

    14.42

  • Sector P/E

    33.76

  • P/E

    57.28

  • EV/EBITDA

    30.13

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    26.46

  • ROCE

    25.84

  • Debt/Equity

    0.50

  • EPS (TTM)

    65.03

  • Dividend Yield

    0

  • Book Value

    247.88

  • Interest Cover

    11.59

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters68.3168.3168.3168.3168.31
FII16.1816.1315.9216.0916.31
DII9.069.149.288.658.35
Public6.456.426.496.947.03
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

51.57

MACD

57.50

50 DMA

4734.73

200 DMA

4209.99

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic6078.735512.335317.574945.934751.174379.533813.13
Fibonacci5512.335295.975162.304945.934729.574595.904379.53
Camarilla5278.565226.645174.724945.935070.885018.964967.04

Pivots Level: Classic

R3

+1132.80

6078.73

R2

+566.40

5512.33

R1

+371.63

5317.57

4945.93
4945.93
Pivot Point
LTP: 4924

S1

-194.77

4751.17

S2

-566.40

4379.53

S3

-1132.80

3813.13

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    4965.26

  • 20-EMA

    4936.79

  • 30-EMA

    4884.03

  • 50-EMA

    4777.03

  • 100-EMA

    4569.56

  • 200-EMA

    4280.78

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 May 2026board-meetingsAccounts, Final Dividend, Raising funds through Debt Instr.
22 May 2026dividend₹9.00 Dividend /Share29 May 2026
27 Mar 2026egm
13 Feb 2026dividend₹29.00 Dividend /Share19 Feb 2026
13 Feb 2026board-meetingsQuarterly Results, Interim Dividend
18 Jan 2026dividendInterim Dividend - Rs 29 Per Share19 Feb 2026
07 Nov 2025board-meetingsQuarterly Results
04 Jul 2025agm
20 May 2025dividend₹6.00 Dividend /Share20 Jun 2025
24 Jan 2025dividend₹26.00 Dividend /Share01 Feb 2025

Read More

Peer Comparison

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Torrent Pharmaceuticals Ltd About

Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1972

Headquarters

CEO

Samir Mehta

Employees

Contact

Website icon

Website

http://www.torrentpharma.com

Email icon

Email

investorservices@torrentpharma.com

Phone icon

Phone

91-79-26599000

Location icon

Location

Torrent House, Off Ashram Road, Ahmedabad, Gujarat, 380009

Read More

Torrent Pharmaceuticals Ltd Company History

YearHistory
2019
  • Amended AOA/MOA.
  • Signed licensing agreement with Glenmark for co-marketing Remogliflozin Etabonate.
  • Changed Registrar & Share Transfer Agent to KFIN TECHNOLOGIES PRIVATE LIMITED.
2021
  • USFDA inspection at Levittown manufacturing facility.
  • Introduced molnupiravir as Molnutor®.
  • Entered Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19.
2022
  • Acquired 100% stake in Curatio Health Care Private Limited.
  • Recommended bonus shares in 1:1 ratio.
2023
  • Signed licensing agreement with Zydus for co-marketing Saroglitazar Mg.
  • Started construction of Virochannagar manufacturing facility.
  • Received EIR from US FDA for Dahej facility.
2024
  • Entered into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals for novel GI drug.
  • Commissioned subsidiaries in Colombia and Chile.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
UBS PRINCIPAL CAPITAL ASIA LIMITEDblockSell448103252.123 Jan 2025
UBS AGblockBuy448103252.123 Jan 2025
TORRENT INVESTMENTS PRIVATE LIMITEDbulkSell49720203103.0730 Oct 2024
TORRENT INVESTMENTS PRIVATE LIMITEDbulkSell49720203104.430 Oct 2024
SEB ASIENFOND EX JAPANblockBuy632942691.207 Mar 2024
SEB FUND 3 SEB PENSION FUNDblockSell632942691.207 Mar 2024
BNP PARIBAS ARBITRAGEblockSell555612507.0525 Jan 2024
SOCIETE GENERALEblockBuy4746292507.0525 Jan 2024
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUNDblockBuy473222507.0525 Jan 2024
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUNDblockBuy43562507.0525 Jan 2024

Read More

Torrent Pharmaceuticals Ltd News

Torrent Pharma posts Q1FY27 results

Torrent Pharmaceuticals Limited has released the audio recording of its conference call with analysts and investors regarding financial results for the quarter ended June 30, 2026.

30 Jul 2026

companies

Torrent Pharma restructures senior management roles

Torrent Pharmaceuticals Ltd has notified exchanges that Hasmukh Patel, Sushil Jaiswal, and Sunil Nadkarni cease to be Senior Management Personnel effective July 30, 2026, due to a change in reporting structure.

30 Jul 2026

companies

Torrent Pharma Q1FY27: Revenue surges 55% to ₹4,921 cr

Torrent Pharma reports consolidated revenue of ₹4,921 crore and net profit of ₹566 crore for Q1FY27, driven by the JB Pharma amalgamation and strong India business growth.

30 Jul 2026

companies

Torrent Pharma Appoints Shanti Ekambaram as Independent Director

Torrent Pharmaceuticals appoints Shanti Ekambaram as Additional Independent Director. She currently serves on boards of Kotak Mahindra Bank, Kotak Mahindra Capital, Kotak Securities, and Havells India.

28 Jul 2026

companies

Torrent Pharma equity shares from JB Chemicals amalgamation list July 28

Torrent Pharmaceuticals Ltd receives final listing approval for 4.19 crore equity shares issued under the JB Chemicals amalgamation scheme. Trading commences on NSE and BSE on July 28, 2026.

27 Jul 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number